Delivery Order SPE2DB22D1202-SPE2DB25FVJK6
- Not listed
- The Defense Logistics Agency awarded a delivery order contract valued at $2,288.30 to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, a combination antibiotic and anti-inflammatory medication used for ear infections. This competitively awarded, firm fixed-price delivery order was issued on August 20, 2025, with an ultimate completion date of August 21, 2025. The product will be delivered to the Conshohocken, Pennsylvania location, which serves...
- The Defense Logistics Agency awarded a delivery order valued at $1,594.26 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, a pharmaceutical product used for ear infections combining an antibiotic and corticosteroid. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by May 30, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $9,466.15 to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin-Dexamethasone Otic Suspension (7.5 mL), an antibiotic-corticosteroid combination medication used to treat ear infections. This non-set-aside, firm fixed-price delivery order was competitively awarded on August 26, 2025, with an ultimate completion date of August 27, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Ciprofloxacin-Dexamethasone Otic Suspension 7.5mL, a combination antibiotic-corticosteroid medication used to treat ear infections. This firm fixed-price delivery order has a ceiling value of $3,138.24 and is scheduled for completion by July 15, 2025. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a $2,100.00 firm fixed price delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, a combination antibiotic and corticosteroid medication used to treat ear infections. The contract, which was competitively awarded with no set-aside designation, was executed on August 18, 2025, with an ultimate completion date of August 19, 2025. Performance will take place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $5,497.61 delivery order to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension (7.5mL), a combination antibiotic and corticosteroid medication used to treat ear infections. This firm fixed price contract, with an ultimate completion date of October 27, 2025, represents a non-set-aside competitive award supporting federal medical procurement needs. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,594.26 for Ciprofloxacin-Dexamethasone otic suspension (7.5mL) with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award represents a single transaction under the company's broader...
- The Defense Logistics Agency awarded a delivery order valued at $2,579.27 to AmerisourceBergen Drug Corp for the supply of Ciprofloxacin-Dexamethasone Otic Suspension in 7.5mL units. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order is scheduled for completion by November 17, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract, this delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,723.16 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, a combination antibiotic and corticosteroid pharmaceutical product used to treat bacterial ear infections. The contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, utilizes firm fixed price pricing under a non-competitive, non-set-aside delivery order structure. Performance will be executed from...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,244.47 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML on June 18, 2025, with completion scheduled for June 20, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a small-value pharmaceutical supply transaction...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVJK6Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,106.69 to AmerisourceBergen Drug Corp for Ciprofloxacin-Dexamethasone Otic Suspension 7.5ML, a combination antibiotic and anti-inflammatory medication used to treat ear infections. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by August 27, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary operations. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle provides comprehensive pharmaceutical support to military healthcare programs globally, enabling the delivery of a broad range of pharmaceutical products, medical supplies, vaccines, and specialty medications. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen maintains an extensive portfolio of competitively awarded contracts with the DLA and Defense Health Agency, positioning it as a key supplier for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 8/26/25 |